NL-OMON39568已完成不适用
Metastases of cutaneous squamous cell carcinoma in organ transplant recipients - The *SCOPE-ITSCC metastases study* - SCOPE-ITSCC metastases study
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 300
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 18 至 99(—)
入选标准
- •Organ-transplant recipients (OTR).
- •Histologically proven cutaneous invasive SCC at time of inclusion.
排除标准
- •Lack of consent.
研究者
相似试验
进行中(未招募)
不适用
Evaluation of factors that worsen survival in metastatic patients of skin carcinomaimmunosuppressionsurgerytransplantationnomogramsE02.095.465.425.450Q65.070C04.557.470.200.400Q65.070.010E01.789.650squamous cell carcinomaRBR-9wt2wjGiulianno Molina de Melo
进行中(未招募)
不适用
Skin cancer with spread to the parotid: evaluation of factors that worsen the clinical pictureRBR-36vxx7Giulianno Molina de Melo
进行中(未招募)
1 期
Risk of Skin Cancer on Skin Areas Treated with Ingenol Mebutate Gel, 0.015% and Imiquimod Cream, 5%EUCTR2012-003112-31-DEEO Pharma A/S480
进行中(未招募)
1 期
Risk of Skin Cancer on Skin Areas Treated with Ingenol Mebutate Gel, 0.015% and Imiquimod Cream, 5%EUCTR2012-003112-31-FREO Pharma A/S480
进行中(未招募)
不适用
Risk of Skin Cancer on Skin Areas Treated with Ingenol Mebutate Gel, 0.015% and Imiquimod Cream, 5%EUCTR2012-003112-31-GBEO Pharma A/S480
